Company: IMCR
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001671927-25-000006
Chunk: 2

Company: Immunocore Holdings plc
Filing Date: 2025-02-26
Form: 10-K
Item: Item 15
Chunk 2
---
Item 15.    Exhibits and Financial Statement Schedules

Incorporation by ReferenceExhibitNumberDescriptionSchedule/FormFileNumberExhibitFiling Date3.1Articles of Association of Immunocore Holdings plc10-Q001-399923.1August 8, 20244.1Deposit Agreement20-F001-399922.2March 25, 20214.2Form of American Depositary Receipt (included in Exhibit 4.1)20-F001-399922.3March 25, 20214.3Description of Registered Securities20-F001-399922.4March 25, 20214.4Indenture, dated as of February 2, 2024, by and between the Company and U.S. Bank Trust Company, National Association, as Trustee.8-K001-399924.1February 2, 20244.5Form of Global Note, representing the Company’s 2.50% Convertible Senior Notes due 2030 (included as Exhibit A to the Indenture filed as Exhibit 4.1).8-K001-399924.2February 2, 202410.1Subscription Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated February 3, 2021F-1/A333-2521664.3February 3, 202110.2Amended and Restated Global Access Commitments Agreement, dated as of March 2, 2020, between the Registrant and the Bill & Melinda Gates FoundationF-1333-25216610.11January 15, 202110.3†First Amendment to the Amended and Restated Global Access Commitments Agreement, dated as of February 3, 2021, between the Registrant and the Bill & Melinda Gates FoundationF-1/A333-25216610.12February 3, 202110.4Lease, dated as of March 28, 2017, between the Registrant and MEPC MILTON PARK NO. 1 LIMITED and MEPC MILTON PARK NO. 2 LIMITED, on behalf of MEPC Milton LPF-1333-25216610.13January 15, 202110.5Lease, dated as of December 28, 2017, between the Registrant and MEPC MILTON PARK NO. 1 LIMITED and MEPC MILTON PARK NO. 2 LIMITED, on behalf of MEPC Milton